These changes together cause large-scale effects on DNA methylation and gene expression, and in final consequence, associate with cell fate decisions towards oligodendroglioma- (IDH-O) or astrocytoma- (IDH-A), as well as GBM(IDH-wt)-like tumour cell lineages with different prognostic impact [45]. The gene discussed is IDH2; the disease is oligodendroglioma.